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Abstract:  It is now commonplace for historians to say medical genetics began around sixty years 
ago with the synthesis and convergence of human genetics and cytological techniques in 
European centres which, in turn, were disseminated to centres in the United States in a more or 
less straightforward manner to become a new field of expertise in medicine and clinical research, 
i.e., cytogenetics. In this article, we show how the early histories of cytogenetics in Canada and 
Mexico unfolded against strikingly different backgrounds in clinical research and the delivery of 
health care. A key argument follows that the field of cytogenetics did not necessarily come 
together and develop the same way in all countries. The article begins with a brief background to 
the history of human cytogenetics. There follows two sections outlining the early adoption of 
cytogenetics in Canada and Mexico. Conclusions are then drawn using comparisons of the 
different ways local determinants affected adoption. This leads, in a final step, to suggestions for 
directions for future study concerning the ways circuits of practices, collaborative research, and 
transfers of knowledge have shaped the ways that cytogenetics has been organised in medicine 
around the world. 
Keywords: Medical Genetics, Cytogenetics, Karyotyping, Transnational perspective on history, 
Entangled histories 
  
2 
 
1. Introduction 
Within the clinic, medicine became geneticized since the 1930s when physicians incorporated 
genetics (“slowly at first, then with increasing vigor”), to explain health and disease. As Comfort 
has shown, medical genetics emerged as a hybrid of science and medicine “with the tensions, 
negotiations, and alliances between the competing styles and interests of the scientist and the 
clinician.”1 In this biomedical space, cells and chromosomes became places of knowledge 
production for explaining health and disease, inherited or congenital characters, inner or 
environmentaly produced. As Santesmases has shown, cytological evidence used by medical 
doctors, were the  major contributions to the advancement of human genetics from a medical 
standpoint.2 
Although the classic narrative acknowledges that medical genetics began approximately 60 years 
ago, at the end of the 1950s, with advancements in the science of human genetics preceding it 
from the end of World War II onward, 3 historians of science have not entirely, as Müller-Wille 
and his colleagues have argued, been been entirely successful in providing a coherent alternative 
to this widespread view. Nevertheless there is  general agreement surrounding the idea that, 
although medical genetics was developed by the 1930s, the interplay of radiation damage and 
genetics expanded after the war. “WWII is a watershed in the history of heredity research when 
medical genetics began to privilege the individual over the collective, and population approaches 
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replaced racial typologies.”4 The end of the World War II brought significant changes not only 
social and cultural, but also scientific and technological. As stated by Cambrosio and Keating, 
after the atomic bombs, Western medicine resulted in the emergence of new practices based on 
the direct interaction of biology (specially genetics) and medicine,5 giving rise to postwar 
biomedicine characterized by focusing on cells and molecules. 6 In the post-war years, when 
there were growing international interests in studying the effects of radiation on human 
populations, human genetics was reconfigured. Indeed, Susan Lindee has described this 
phenomenon as “an explosion of new institutions, disciplines, databases, interventions, practices, 
techniques, and ideas turned technically driven human genetics from a medical backwater to an 
exotic and appealing medical research frontier.” 7 More particularly, Diane Paul maintained the 
investigation of chromosomal anomalies in the late 1950s “laid the scientific groundwork for 
prenatal diagnosis.” 8 In post-1945, knowledge on human heredity depended on the circulation of 
people, medical and experimental practices, and methods within very different disciplinary 
contexts. As Mülle-Wille and colleagues have said, “such transfers not only mediated 
interdisciplinary relations, they were also able to induce concurrent transformations in previously 
separated fields” that was the case of karyotyping techniques. 9 
                                                          
4
 Gausemeier 'et al.' (2013), pp. 6. 
5
 Cambrosio et al (2006). See also Keating and Cambrosio (2003). 
6
 Gaudellière (2002).  
7
 Lindee (2002), pp. 75. 
8
 Paul (1998), pp. 141. 
9
 Gausemeier 'et al.' (2013), pp. 9, see also de Chadarevian (2013). 
4 
 
The synthesis and convergence of human genetics and cytological techniques in European 
centres feature prominently in these accounts of the origins of medical genetics. These are said to 
have produced a new field of knowledge, i.e., cytogenetics, that would subsequently be 
disseminated to centres in the United States in the 1960s. Cytogenetics was in fact the first in a 
succession of new technological advancements that would permit scientists and clinicians to 
investigate diagnostically the genetic basis of disease. In a subsequent phase, cytogenetics, 
biochemical genetics, genetic counselling, and, after the mid-1980s, molecular genetics 
amalgamated into a formal medical specialty, i.e., “medical genetics,” around which the 
researchers and service providers involved worked collectively to build an environment which 
provided the resources needed to ensure that governments and the public would acknowledge the 
value of the expertise being offered. 
Our contribution to the history of early cytogenetics begins by broadening the scope of 
inquiry beyond the understanding that medico-scientific breakthroughs that originated in 
European centres in the late 1950s diffused in a more or less straightforward manner to become a 
new field of expertise in medicine and clinical research, i.e., cytogenetics.  A key argument 
follows that the field of cytogenetics did not necessarily come together and develop the same 
way in all countries. Correspondingly, we believe it is inappropriate to suggest that 
developments in any single country can be regarded as exemplary for what has occurred 
elsewhere and against which developments in other national and supranational settings can be 
ranked and compared in relative terms. Indeed, historians of specialty formation in medicine in 
the past have convincingly shown that the phenomenon of medical specialisation is not by nature 
and by theoretical definition independent of local variants of the specialty practices to be found 
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in different national settings. 12 On a high level of generality, histories of medical specialties 
around the world have consistently indicated that individual specialties develop as more or less 
coherent sets of practices evolving from a more or less unitary perspective (i.e., professional 
medicine). However, detailed investigation has revealed the important contribution of complex 
intraprofessional arrangements and resource sharing relationships that are involved in achieving 
the emergence of closely defined obdurate structures and standards of practice. Accordingly, in 
what follows, we concentrate on the complexity of intraprofessional arrangements and resource 
sharing relationships that have contributed to the growth and development of cytogenetics in 
Canada and Mexico. 
Moving beyond the confines of what occurred in the United States, our study of early 
cytogenetics gives accounts of two countries where the taking up of cytogenetics was influenced 
by strikingly different backgrounds in clinical research and health care delivery. Unlike the 
United States, where a broad cohesive national strategy has notably never been developed for 
genetic health care, 13 the structural development of medico-scientific interest in cytogenetics in 
both Canada and Mexico has followed closely the prescriptions of national programs and 
government policies.  At the same time, we submit, Canada and Mexico each represent very 
different cases. Whereas the path that Canadian cytogenetics followed would focus on diagnostic 
testing, counselling and the formation of laboratories in university-hospital settings, the 
development and growth of Mexican cytogenetics was strongly tied to clinical research and 
investigating the chromosomal basis of population health. We will see that in Canada, in what 
follows, that the emphasis was all on testing, counselling and the clinic, while there was much 
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greater funding and institutional emphasis on research in Mexico.. These differences allow us to 
say that the local contexts were important in the adoption and development of cytogenetics in 
Canada and Mexico, thus contributing differently to the global fields of human genetics and 
medical genetics. 
2. Some Background: What is Cytogenetics?  
Simply put, cytogenetics is “the study of structure, function, and evolution of chromosomes.” 14 
The term “chromosome” refers to any of numerous threadlike bodies, consisting of chromatin, 
that carry genes in a linear order in the nucleus of the cells that make up organisms. Carl 
Wilhelm von Nägeli was the first to describe thread-like structures in the nuclei of plant cells in 
the 1840s. Walther Flemming later published the first drawn illustrations of what he called 
“chromatin” in 1882. He used aniline dyes to make the structure of the chromatin more visible 
under the microscope. Eventually, in 1888, the term “chromosome” (Greek for “stained body”) 
was employed by Wilhelm von Waldeyer. 15  
The consensus among historians of science is that cytogenetics originally took shape as a 
discipline around the idea that chromosomes were the physical carriers of the hereditary material 
of living beings. 16 More specifically, in the first decades of the twentieth century, the 
chromosomal theory of heredity, also known as Boveri-Sutton theory, merged Gregor Mendel’s 
theory of heredity with the evidence then available concerning chromosomes to posit 
chromosomes as the physical sites on which “genes,” as Wilhelm Johannsen called them in 1909, 
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were positioned. It is noteworthy that Mendel’s theory of heredity had previously been published 
in 1866 in the Margraviate of Moravia, but remained relatively unknown until it was 
rediscovered and experimentally substantiated in 1900 independently by Carl Correns, Hugo de 
Vries, and Erich Tschermak in the Netherlands and Germany. The merger with the chromosomal 
theory of heredity allowed for the genetic theories of the early twentieth century to be explained 
in cytological terms and for scientists to make experimentally testable predictions concerning the 
transmission of heritable traits across generations.  It was Walter Sutton who subsequently 
coined the term “cytogenetics” to refer to the study of chromosomes; cytogenetics being a 
combination of the disciplines of cytology and genetics. 17 
Technical advancements in the nineteenth century in optical lenses, stains and tissue 
manipulation contributed significantly to the growth and development of cytogenetics. However, 
progress in human cytogenetics was slowed down due to an inability to arrive at consensus on 
the correct count of chromosomes in human cells. From the 1890s to the 1920s, the number of 
chromosomes reported varied from eight to over fifty. 18 Theophilus Painter published the 
number as forty-eight in a study of meiotic chromosomes in 1923, a number that was generally 
accepted for many years. In 1956, Joe-Hin Tijo and Albert Levan of Sweden provided what is 
today regarded as the correct number of forty-six. New techniques for analysing chromosome 
anomalies followed that gained the attention of clinical researchers such as the ones studied in 
this article.  
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Down syndrome was the first anomaly – an autosomal trisomy – to be identified using 
chromosome analysis. Jérôme Lejeune of the Centre National de la Recherche Scientifique 
(CNRS) of Paris showed a slide of a karyotype which indicated the presence of the anomaly at 
the International Genetics Congress in Montreal in August 1958. By the end of 1958 there were 
at least four groups at Uppsala, Edinburgh, London, and Harwell who were, like the team in 
Paris, actively studying chromosomes and a variety of syndromes. On Lejeune’s return to 
France, the CNRS hurriedly published with the Academy of Sciences “as a matter of urgency, in 
order to overtake the Anglo-Saxon teams.” 19  This was followed soon thereafter by papers 
detailing the identification of Turner syndrome and Klinefelter syndrome. 20 In what follows, we 
trace how the new techniques for analysing chromosome were taken up in two countries outside 
of Europe: Canada and Mexico.  
3. The Beginning of Cytogenetics in Canada 
Recognition of the opportunities for tumour analysis afforded by cytogenetics can be traced in 
Canada as early as the late 1920s. Pierre Masson, an eminent French histopathologist with an 
interest in human tumours, arrived in the province of Quebec in 1927 to become Director of 
Anatomic Pathology at Hôpital Notre-Dame and Director of the Department of Pathology at 
Université de Montréal. The founding of the Service of Anatomic Pathology at Hôtel-Dieu de 
Québec followed in 1946. 21 Even so, Jacques Gagnon, originally a pathologist at Université de 
Montréal, is generally credited with first bringing cytogenetic techniques back to l’Hôpital Ste-
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Justine after studying in 1959 with Jérôme Lejeune at the CNRS in Paris. 22 Louis Dallaire would 
subsequently set up a service laboratory for the Montreal Children’s Hospital in 1964 before 
moving on to set up similar facilities at l’Hôpital Ste-Justine and l’Université de Montréal. Louis 
Dallaire had originally applied for graduate work in human genetics after obtaining his physician 
qualifications and completing, first an internship at Université de Laval in Quebec City and, 
second, a paediatric residency at the Montreal Children’s Hospital. Following this he went on to 
study cytogenetics with Paul Polani at Guy’s Hospital, London, and Michael Court Brown at the 
radiation unit of Edinburgh Western General Hospital. Dallaire subsequently returned to Canada 
to become Mead Johnson Fellow in medical genetics at the Montreal Children’s Hospital while 
pursuing doctorate studies under the supervision of F. Clarke Fraser, then staff geneticist at 
McGill University.23  
The resources obtained to support the establishment of the cytogenetic facilities at 
l’Hôpital Ste-Justine, l’Université de Montréal, l’Université de Laval, and the Montreal 
Children’s Hospital all came from established pathology and paediatric departments of the 
respective university-hospital settings that housed them. In each case, the number and variety of 
illness groups being investigated were very limited – too limited to justify independent budgets. 
Accordingly, cytogenetics staff found themselves grouped together with the staff geneticists of 
the hospitals who were called upon to perform syndrome analysis and prenatal diagnosis and, 
secondly, laboratory personnel who carried out biochemical assays to test for metabolic 
disorders. Syndrome analysis and the testing for metabolic disorders, like chromosome disorders, 
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may or may not be genetic in nature. The salient point is that, in the 1960s, the precise definition 
of genetic diseases was still in question as was the extent to which the genetic basis of disease 
could be investigated. Placed side-by-side, those individuals involved in cytogenetics, syndrome 
analysis, prenatal analysis, and biochemical analysis increasingly  came to view themselves as 
being enmeshed in a common enterprise. Within  a decade they took steps that would give rise to 
the organisation of a province-wide network of genetics-related health care services that became 
known as Le Réseau de la Médecine Génétique du Québec (The Quebec Network of Genetic 
Medicine).  
Le Réseau de la Médecine Génétique du Québec was formed in October 1969 on the 
recommendation of four heads of the paediatrics departments at the Centre Hospitalier 
Universitaire de Laval, Le Centre Hospitalier Universitaire de Sherbrooke, the Montreal 
Children’s Hospital and l’Hôpital Ste-Justine. In addition to Dallaire, Le Réseau included Claude 
Leberge, who had taken his medical and paediatric training at Laval, followed by Ph.D. studies 
under Victor McKusick at The Johns Hopkins University, Richard Gagné, cytogeneticist and 
staff geneticist at the Centre Hospitalier Universitaire de Laval, Charles Scriver of McGill, who 
set up the de Belle Laboratory of Biochemical Genetics at the Montreal Children’s Hospital, and 
Carol Clow of McGill. The original mandate of Le Réseau was to develop a centralised program 
for the early detection of metabolic diseases in newborns.  By the mid-1970s, Le Réseau 
provided a range of diagnostic services, counselling and treatment for a variety of paediatric 
disorders including chromosomal anomalies. 24 
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It is reasonable to conclude that Quebec was the first province to establish cytogenetics in 
Canadian medicine. However, it would be wrong to assume that cytogenetics disseminated from 
Quebec to the rest of Canada in a kind of centre-periphery relationship. Since 1972, Canada’s 
health-care system  has been predominantly publicly financed and delivered by a combination of 
funds and policies originating at the federal level and operating at the level of the provincial 
governments. 25 Federal law mandates health insurance coverage and contribution levels, but 
physicians’ associations contract with provincial funders. Medical associations are generally free 
to oversee the allocation of spending among general practitioners and specialists. Most hospitals 
are private, non-profit corporations, although some hospitals are maintained by the federal 
government (e.g., the Department of National Defence) or provincial and territorial governments 
(e.g., psychiatric hospitals). All hospitals in the territories are administered federally. It was 
against the backdrop of the formative period of the establishment of a national health insurance 
system that genetic health care services in Canada took shape. At the same time, each provincial 
genetic health care service followed its own unique scheme of local development.  
Of the eleven sites in Canada that provided some combination of genetic counselling and 
laboratory services in 1970, only three in Quebec were set up by individuals who had studied in 
Quebec. 26 The remaining eight sites (British Columbia, Alberta, Saskatchewan, Manitoba, 
Ontario, Nova Scotia, Newfoundland) were set up by individuals who originally trained in the 
UK and/or the United States. While the university-hospital setting at Toronto, Ontario was a 
major point of training in genetic counselling, cytogenetics and biochemical genetics did not 
achieve mature status until the 1980s. The Atlantic Provinces (Nova Scotia, New Brunswick, 
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P.E.I., Newfoundland) made a lot of resource-sharing arrangements for counselling and 
laboratory services, with a centre at Halifax (Nova Scotia) and one at St. John’s (Newfoundland) 
acting as centralised services for people from multiple provinces. By contrast, the case of 
cytogenetics in the province Manitoba is exceptional in so far as experts were recruited from 
abroad and interprovincially to start up genetic services. It thus merits more attention. 
In 1960, the head of the Winnipeg Rh Laboratory, Bruce Chown, and the head of 
paediatrics, Harry Medovy, at the University of Manitoba recruited Irene Uchida, trained in 
genetics at the University of Toronto, Ontario and subsequently in Drosophila genetics in 
Madison, Wisconsin. 27  Once in Winnipeg, Uchida secured a grant of $250,000 for five years 
from the National March of Dimes Foundation (United States) to do cytogenetics research on 
Down syndrome.  With these funds, she hired a group of local laboratory technicians and 
assembled a group of postdoctoral fellows in cytology who were working in the Department of 
Plant Science at the University of Manitoba. Through the 1960s, she pursued research, did some 
genetics instruction in the Department of Paediatrics, and helped to set up a cytogenetics service 
in what eventually became the Department of Medical Genetics at Children’s Hospital of 
Winnipeg. When she departed Winnipeg in 1969 to start up a chromosome laboratory at the new 
medical school at McMaster University in Ontario, Harry Medovy set about recruiting John L. 
Hamerton, then head of the cytogenetics section of the Paediatric Research Unit of Guy’s 
Hospital Medical School in London, England.28 Hamerton had been recommended to Medovy by 
a London (Ontario) neuroanatomist, Murray Barr, who had met Hamerton in 1958. Hamerton, in 
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turn, assembled a team of individuals from England to work with three local laboratory assistants 
in Winnipeg. Funds were solicited and received for laboratory equipment purchases from the 
Children’s Hospital Research Fund (Winnipeg). By the early 1970s, Hamerton had been 
successful in acquiring two major research grants: a Public Health Research Program grant to 
survey the births at the Women’s Hospital (Winnipeg) for chromosome abnomalies over a three 
year period, and a Medical Research Council (MRC Canada) grant for somatic cell genetic 
studies to develop cell hybrids and mutant cell lines. The MRC also awarded an additional major 
equipment grant. A formal genetic counselling clinic was started in 1969 by Hamerton in 
conjunction with a service cytogenetics component run out of a cytogenetics research laboratory. 
While it can be said that there was considerable difference in the way that the structural 
development of institution-based interests in cytogenetics began in the various Canadian 
provinces, it is noteworthy that each provincial site was established in a university-hospital 
setting – often a paediatric department – which provided what might best be described as a 
“protective niches” in which cytogenetic laboratory facilities could be nurtured. These facilities 
remained small and entirely reliant on the larger departments that housed them until the early 
years of the 1970s when a concerted effort was made to assess the rate and direction of genetic 
health services at the national level in Canada. This occurred when the geneticists involved in 
genetic counselling realised that they were spending proportionally less time in their research 
laboratories and more time in the clinics they were assigned to. A survey by questionnaire 
circulated by the Genetics Society of Canada confirmed that an increase in demand for genetic 
counselling had occurred and attributed the increase to innovations in laboratory and prenatal 
counselling services. The idea of creating a formal organisation to develop and maintain 
standards of genetic health services emerged from this that resulted in a coalition of scientists 
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and clinicians providing counselling and laboratory services to form a corporation to be known 
as the Canadian College of Medical Geneticists (CCMG). The CCMG would go on to pave the 
way similar developments in the Netherlands, the United States, Finland, Sweden, Germany, 
France, and Denmark. The application for the incorporation of the College was recorded by the 
Ministry of Consumer and Corporate Affairs on January 13, 1976. The same year, the CCMG 
made a formal application to the Royal College of Physicians and Surgeons of Canada for the 
recognition of Medical Genetics as a new medical specialty.  
It was not until 1988 that the Specialty and Manpower Committee of the Royal College 
supported the creation of medical genetics as a free-standing specialty in Canada. By that time, 
eighteen centres in eight provinces were providing counselling and laboratory services. All 
belonged to university-hospital affiliated programs, with the exception of three centres in 
Ontario. In addition, nine provinces had established outreach programs whereby staff from 
genetics centres was dispatched on a regular basis to hold clinics sites in outlying areas. Of the 
sixteen Canadian universities with faculties of medicine, seven offered Royal College accredited 
residency training programs in medical genetics, and seven offered training programs accredited 
by the Canadian College of Medical Geneticists. In practical terms, this meant that holders of 
MD degrees could either apply for certification as medical genetics specialists after completing a 
defined period of specialty residency in a program recognised by the Royal College, or, after 
obtaining certification as specialists in another area of practice recognised by the Royal College, 
apply for certification as clinical geneticists recognized by the Canadian College of Medical 
Geneticists. Ten years after specialty recognition, only two staff geneticists were employed in 
provincial genetics centres with just Royal College training in medical genetics. At the same 
time, a healthy percentage (44%) of the MD-geneticists was certified by both bodies, indicating a 
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relatively high level of acceptance in the field for the RCPSC medical geneticist category. The 
other fifty three per cent of clinicians providing counselling and consultation in genetics centres, 
by contrast, were made up of individuals who had entered the field prior to specialty formation in 
1989.  
As a final point, it is significant that the occupational role of MD-geneticists evolved in 
relation to the roles of other medical specialist categories. In brief, two broad sets of activities 
can be identified. The first set falls under a general category of prenatal care in pregnancy and 
childbirth, and overlapped with the services of obstetrics and gynaecology. Activities in this set 
continue to be referred to by their function: ‘prenatal diagnosis’. This can be distinguished from 
what is called ‘general genetics’. General genetics is a catch-all category for activities involving 
infants, children and adults. As a set of activities unto itself, it can be further divided into three 
subsets. Activities in the first subset overlap with the area of neonatology. This involves the 
diagnosis and management of congenital anomalies and diseases in newborns. The second subset 
takes up broader paediatric concerns and focuses on the diagnosis and management of disorders 
in children.  Finally, the third subset deals with adult-onset diseases and screening for carriers of 
heritable conditions. In this regard, the nature of the interface with other medical specialists 
shifts depending on whether the patient is a pregnant woman, an infant, a child, or an adult. 
 
4. The Beginning of Cytogenetics in Mexico 
Spanish-born Mexican pediatrician Salvador Armendares is reputed to be the first Mexican 
physician with postgraduate studies in human genetics. After obtaining his B.Sc. in 1950 at the 
National Autonomous University of Mexico (UNAM), Armendares specialised in pediatrics at 
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the Children’s Hospital of Mexico in 1956, working from 1961 to 1962 as a pediatrician and 
researcher at the Medical National Center (CMN) Gynecology and Obstetrics Hospital #2 and 
later on at the CMN Pediatric Hospital, both belonging to the Instituto Mexicano del Seguro 
Social (IMSS). In 1964, he was granted a fellowship from UNAM to spend two years as a 
graduate student at the British Medical Research Council in Oxford, England, under the 
supervision of Alan C. Stevenson. Stevenson, at the time, was the dean of the Council and 
considered one of the first physicians to work in the fields of human and medical genetics.  
Armendares and Stevenson had become acquainted when Stevenson had come to the 
School of Medicine of UNAM to present plans for the World Health Organization (WHO) 
sponsored “International Project on Congenital Malformations.” Human geneticists James V. 
Neel, J. A. Fraser Roberts, Stevenson and epidemiologist William J. Shull had previously met in 
1959 in Ann Arbor, Michigan to plan a simple prospective study of the malformations occurring 
in a consecutive series of births in hospitals in several countries. The WHO agreed to support the 
Project with Stevenson as the principal investigator. Sixteen countries were chosen to participate, 
including Mexico. The WHO sent letters to the Ministries of Health for a number of countries 
explaining the goals of the research goal and requesting participation. After sending the 
invitation letter to each country’s Ministry of Health, a visit was paid by WHO personnel to 
recruit obstetricians and pediatricians who might be interested in taking part in the study. The 
main requirements for the centers chosen were that they had to be maternity hospitals large 
enough to guarantee the efficiency of the study. This meant that the maternity hospitals would 
have to be rather large, expecting a minimum of 10,000 births over the two years of the project. 
17 
 
Argentina, Chile, Colombia, Mexico and Panama were among the Latin American countries 
taking part in this research. 29 
The collection of data began in 1961 and ended in 1964. This involved the recording of 
each single birth in white cards, and similar yellow cards for the second member of a twin pair 
(for the second and third members of triplets on the front and back). The cards were printed at 
Oxford in English, Spanish, Serbo-Croat and Czech. They were serially numbered and posted in 
batches to the various centers. After completion, the cards were returned to Oxford, indicating 
the cause of death and up to six malformations of each child along with the other information 
from each birth. Physicians were asked to describe any malformation found to avoid a single 
diagnostic term. If a syndrome was mentioned they were asked to describe all the malformations 
found in the child as well as to give a general diagnosis.30 This study encouraged the pursuit of 
population studies on certain chromosomal anomalies, like Down Syndrome, that had not 
previously been done in Mexico.  
Among the findings of the International Project on Congenital Malformations that were 
of particular interest in the context of Mexico were “the large contribution of neural tube defects 
to foetal wastage in most countries and the significant correlations of frequencies of these defects 
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over the twenty-four recording centres; the unexplained correlation in frequency between neural 
tube defects and dizygous twinning; the marked association of consanguinity of parents with 
increased stillbirth rates and frequency of early death of the infant, these frequencies being 
highest where parents are most closely related; and the demonstration that, if malformations 
known to be due to the expression of single recessive gene mutations are ignored, consanguinity 
of parents is demonstrably associated in these data with neural tube defect frequencies only.” 31 
Other malformations recorded were harelip and cleft palate, malformations of the gut, 
malformations of urogenital tract, and Down Syndrome. In the latter, unless careful clinical 
examinations were carried out in the newborns, studies were supplemented by dermatoglyphic 
and chromosome data. It is worth noticing that, according to the study, there was a relative high 
frequency of Down Syndrome in Mexico. The study also showed that in Mexico City the 
proportion of all pre-28th week losses that occurs between the 17th and 27th weeks was much 
higher than elsewhere, indicating that further analysis of the information collected might serve to 
identify the characteristics of a high-risk group of mothers and give clues to the etiology.  
Second, and concurrently, the International Project on Congenital Malformations 
permitted Armendares to join and contribute to the international research networks on human 
and medical genetics. Soon after his return to Mexico from England, Armendares was able to 
establish the first Unit on Human Genetics (Unidad de Genética Humana, UGH) and, a couple of 
years later, the first graduate program on medical genetics for physicians endorsed by the 
UNAM. Although initially it did not include investigation, once consolidated in the 1960s, 
research groups began to be formed especially at the General, Gynecology and Obstetrics, and 
Oncology Hospitals. According to Mateos and Beyer, it was in 1966 that the Scientific Research 
                                                          
31
 Stevenson 'et al.' (1966), pp. 29.  
19 
 
Department (Departamento de Investigación Científica, DIC) was established in the IMSS, 
funded by a million-dollar donation from the Ford Foundation. 32 This department paved the way 
for the development of cytogenetics in Mexico with a strong emphasis in medical practice 
because it provided the budget, the space and the spirit to found the first unit in human genetics 
in the country. 
Colombian-born Mexican physician Fabio Salamanca and Mexican physician Leonor 
Buentello were the first generation that graduated from the program and soon joined Armendares 
at the unit. It´s worth noticing that Salamanca had studied physiology at the National University 
of Colombia and, years later, taken a diploma on cytogenetics at the University of Minnesota 
under Jorge J. Yunis’s suprervison. On her part, Buentello graduated from the School of 
Medicine at the UNAM, and graduated on virus genetics at Freiburg, Germany under Richard 
von Hass’s supervision. The three of them were the nucleus of the UGH, and began the 
adaptation, standardization and stabilization of the techniques developed at the time for the study 
of human chromosomes. These were used to tackle the specificities of local needs and to develop 
precise diagnostic protocols to provide accurate genetic information to Mexican patients for the 
development of future treatments and prophylaxis (preventive medicine). Armendares (the only 
of the three who had practiced medicine at the hospital) was the first to associate karyotyping 
with genetic counselling, interpreting test results and technical language for the patients or their 
parents at the hospital. 33 Furthermore, the three began to attend international conferences and 
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publish in international journals that contributed to the global knowledge on human genetics.34  
By the end of the 1960s the UGH moved from its original location in a small room in the 
basement of the Paediatric Hospital to an adjoining bigger area where more people were hired 
and more equipment acquired. In 1970 the UGH consisted of ten researchers, twelve technicians 
and assistants, and up to twelve doctoral and postdoctoral students. 
Influenced by the research he conducted at Oxford with Stevenson, Armendares’ genetic 
research agenda at the UGH included population genetics in congenital illnesses, and particular 
disorders such as abnormal growth in Mexican children, malnutrition as a cause of chromosomal 
alterations, and Turner Syndrome, which was not well understood. He also worked on the early 
diagnosis of Down Syndrome. Prior to the adoption of karyotyping, children with Down 
Syndrome in Mexico were diagnosed by looking for a smaller size in the iliac index of the hip. 35  
The location of the unit in the hospital was of crucial importance inasmuch as it allowed human 
geneticists and physicians to combine the clinical practice with the laboratory in a two-way-
traffic. Furthermore, the standardization of the up to date techniques at the UGH was very 
important because they made the karyotype accessible to scrutiny and close examination.  
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Unquestionably, Armendares learned karyotyping techniques in his training at Oxford. 
Among the most important were the ones developed by Moorhead and colleagues in 1960 for 
chromosome preparation using heparin as an anticoagulant – of common use in all the blood 
culture techniques at the time. 36 He also adopted the use of phytohemagglutinin, a protein 
obtained from Phaseolus vulgaris, as a mitotic initiator. 37 In Armendares laboratory these 
techniques were used for leucocyte cultures from peripheral blood. These techniques, for 
example, allowed Armendares and colleagues to do more complete work on Down Syndrome, 
introducing karyotyping as a tool for a more precise diagnosis. 38 On the other hand, more 
attention was paid to techniques for identifying Turner Syndrome. Articles on gonadal 
dysgenesis in patients with Turner Syndrome had been published as early as 1972. Using 
gonadal biopsies, Armendares and Salamanca found that most presented the XO genotype, but a 
series of chromosomal variants appeared in the population studied at low frequencies.39  
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Other materials and methods were used in later studies for the first time in the country. 
For example, buccal smear wab samples stained with aceto-orcein were used for the X chromatin 
determination, and peripheral blood lymphocyte culture was used for chromosomal analysis of 
seventy-four patients from the Pediatric Hospital. These new techniques allowed the geneticists 
at the unit to relate Turner Syndrome with different chromosomal variants.40 This work received 
more than sixty international citations between 1973 and 1985. 44   
As part of the innovation pursued by Mexican geneticist at the Unit, other studies were 
performed towards understanding the frequency of certain illnesses with the occurrence of 
chromosomal alterations, for example, a study published in 1971 on child malnutrition and the 
effect of protein calorie deficiency on genetic material. 45 It was found that there was a 
significant increase in structural anomalies of chromosomes in connection with malnutrition, a 
pending agenda of Post-Revolutionary Mexican governments. These results drew the attention of 
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researchers both inside and outside Mexico, contributing to the development of this line of 
research in both humans and in laboratory animals. Years later, the same authors performed a 
study with other colleagues, published in 1979, to observe the frequency of structural 
chromosomal abnormalities in children with severe malnutrition. They used the frequency of 
sister chromatid exchange (SCE) as a more sensitive method for detecting certain types of 
environmental mutagens. They also used the Perry and Wolff staining technique with Giemsa 
stain published only a few years before in 1974. 46 The results obtained did not show 
overwhelming evidence of an increase in SCE in malnourished as compared to normal children. 
However, what they did find was that the proportion of third or subsequent cell division 
metaphases were significantly higher in malnourished children in comparison to the control 
group. This was compatible with the observations of Armendares and colleagues that in mixed 
cultures of malnourished and normal subjects, metaphases from the former are always more 
numerous than the latter. 47 This suggested the possibility that even if the cell cycle is faster in 
children than in adults, it is much faster still in malnourished children. 48 
Finally, in their work on the C band human chromosome study, Armendares, Salamanca 
and Buentello were capable not only of adopting but also of significantly improving a newly 
acquired technique to study chromosome abnormalities for a local context. In 1970, Pardue and 
Gall described a procedure to localize C-bands in human chromosomes using sodium hydroxide 
as a denaturalizing agent. 49 The next year several papers appeared informing about the drastic 
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changes in chromosome architecture caused by this substance. Margery Shaw and colleagues 
made several modifications reducing the concentration and time of exposure. 50 In 1974 
Salamanca and Armendares developed a new staining technique using barium hydroxide, which 
showed up the C-bands of chromosomes to make this process simpler and more practical. The 
study was carried out on metaphase chromosome from normal and abnormal males and females. 
Chromosomes preparations were obtained according to the usual procedures in blood samples, 
and then treated with barium hydroxide. With this technique many metaphases were observed in 
each study because, even though barium hydroxide was as harmful as NaOH for the 
chromosome structure, it was more soluble and its solubility could be increased with the rise in 
temperature. This technique allowed each chromatid to be observed with its own 
centromere.51Armendares and his colleagues would subsequently take advantage of this 
improved technique to perform future studies. 
The increasing research activity of the members of the UGH and the rapid development 
and adaptation of cytogenetics at clinic settings were very important for the institutionalization 
of human genetics in Mexico. In 1968, the Mexican Association of Human Genetics 
(Associación Mexicana de Genética Humana, AMGH) was established with a strong medical 
component. The Association brought together specialists in the field to promote human resource 
development and research, as well as the teaching of human genetics in Mexico. Its founding 
members were Salvador Armendares, Leonora Buetello, José María Cantú, Alejandro Cuevas, 
Mario Gonzalez Ramos, Susana Kofman, Hector Márquez Monter, Antonio Quiroz, Adolfo 
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Rosado, Mario Salazar Mallén, Carlos Zavala, Maria Teresa Zenzes and Rubén Lisker. Besides 
these, the corresponding foreign members were also elected. The interdisciplinary nature of 
human genetics allowed the inclusion of specialists in other fields such as biochemistry, biology, 
and chemistry. 52 Undoubtedly, the creation of the AMGH gave considerable weight to the 
formation of national and international academic networks, and was an important forum for the 
discussion and dissemination of genetic knowledge.  
In terms of influence beyond Mexico, the organization of the V International Congress of 
Human Genetics held in Mexico in October 1976, was very important as a site of transnational 
collaboration. The first Congress was held in 1956 in Copenhagen as an effort to bring together 
human geneticists from all over the globe to contribute in all aspects of human genetics, 
including clinical practice, research, and education, and to foster international networks of 
collaboration that allow the circulation of people, methods and practices. Due to the international 
collaborations and positioning of Mexican human geneticists, the Permanent Committee of the 
International Conferences of Human Genetics, headed by James Neel, Salvador Armendares, 
F.C. Fraser, J. de Grouchy, and Lionel Penrose among others, the committee decided to give 
Mexico the opportunity to host the meeting. The Mexican Organizing Committee include the 
father of populations genetics in the country Mario Salazar Mallén, Salvador Armendares and his 
close collaborator and friend Rubén Lisker, Héctor Márquez Monter, José María Cantú and 
Fabio Salamanca among others.  This congress was the first to be hosted by a Latin American 
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country, and in its 5 day duration, there were presented more than 200 works on different aspects 
of human genetics. It is worth noticing that the Mexican geneticist not only were at the time 
working at the UGH, but in other research institutions that were developping human genetics in 
clinical practice, such as the Children’s Hospital and the Pediatric Hospital, and many different 
state institutions. 
Years later, in 1976, the National Council of Experts in Human Genetics (Consejo 
Nacional de Especialistas en Genética Humana, A.C.) was established, which became the 
Mexican Council of Genetics (Consejo Mexicano de Genética, CMG) in 1998. This was part of 
the Regulatory Committee of Medical Specialties (Consejo Nacional de Especialistas en 
Genética Humana, A.C.), which incorporated 47 Mexican councils and was governed in turn by 
the National Academy of Medicine. There were basically two objectives behind the creation of 
the CMG. The first was to bring together specialists in human genetics, and the second was to 
evaluate specialists who wished to pursue genetic medicine in a peer review system in order to 
ensure high standards of knowledge and training to detect health problems for hereditary 
diseases and genetic counselling. Genetic counselling has been restricted to tertiary hospitals, 
meaning those who give specialised care and conduct research. Counselling in these institutions, 
in principle, can only be given by doctors or specialists certified by the CMG, and is restricted to 
the establishment of family trees, as well as cytogenetic, biochemical and molecular studies to 
establish the probability of patients or their children inheriting a genetic disorder. The CMG was 
thus established as a certification body and conceived as an organization that supports and 
distinguishes medical genetics specialists from other areas. The CMG has kept close ties with the 
AMGH owing to the fact that a considerable number of members belong to both organisations.  
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Today, unlike other groups, the CMG offers courses to its members in organisations such 
as the National Institutes of Pediatrics and Nutrition, the General Hospital, CMN HP, and the 
Western Center for Biomedical Research – the last two being a part of the IMSS. As a result of 
the development of human genetics, the program for Registry and Epidemiological Surveillance 
of External Congenital Malformations was established in 1977. Years later, in 1984 it was 
changed to the National Reference Center for Congenital Malformations in Health (Centro 
Nacional de Referencia de Malformaciones Congénitas en Salud, CNRMCS) as a hospital 
system proposed by the state, which included the Ministry of Health, the IMSS and the ISSSTE. 
This registry started with the goal of having an up-to-date record of malformations, risk factors 
and teratogen monitoring environments. However, by the late 1980s, it had fallen behind with 
respect to keeping reliable records of genetic disorders in Mexico. 
5. Concluding Remarks and Future Directions 
The Johns Hopkins geneticist Victor McKusick famously said in the early 1960s that 
cytogenetics “gave us our organ.” 53 McKusick was alluding to the fact that medical specialties 
have typically each taken on an organ of the body as the focus of their treatment practice. Thus, 
cardiologists have taken possession of the heart as their site of practice and nephrologists the 
liver. On the other hand, it is not clear that the chromosomes constitute an organ site in a manner 
that properly corresponds to hearts, livers, etc. Chromosomes are sites on which the genes are 
located, and cytogenetics  have focused on studying the genetic basis of disease as a 
phenomenon of the entire body. Furthermore, whereas past historical studies on medical 
specialisation have typically focused on specialties that already have mature institutional 
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histories, medical genetics in general – and cytogenetics in particular – is a recent addition to 
medicine. Accordingly, we have mostly stayed within the limits of national frameworks in this 
article to tell the histories of pioneering individuals who brought new techniques, experimental 
procedures, and methods of cytogenetics to Canada and Mexico. In this context, their histories 
show the narrowing of the interest area of individuals involved in creating a specific area of 
expertise, i.e., cytogenetics. This has been useful to the extent that it shows the narratorial 
plurality of new techniques, procedures, and methods being applied to serve different local, 
regional and national purposes. On the other hand, once established as a specific area of 
expertise, the narrowing down of cytogenetics to smaller routine component parts can also be 
seen to have resulted in a variety of roles performed by individuals operating within 
organisational settings that pre-exist cytogenetics. We have discussed some of these 
relationships, but, for reasons of limitation of space, have not fully explored their implications 
from the unitary, global perspective of medicine. 
An important point to be taken away from the article is that what look like coherent sets 
of practices in each country began as loose networks of resource dependencies, personnel, and 
organisations which can be re-configured within the context of local research and health care 
delivery systems. While proficiency in early cytogenetic techniques required training and 
practice, the work of the cytogeneticist required little specialised or expensive equipment or 
supplies. Chromosome analysis, or “karyotyping,” involved photographing what is seen through 
the barrel of a microscope and reordering the chromosomes in accordance with a system of 
chromosome designation. In the early years this meant literally cutting out the photographic 
images of each chromosome, gluing them in order on another piece of paper, and re-
photographing the arrangement for purposes of analysis and filing reports. In the 1960s the 
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number of chromosomal anomalies that the cytogeneticist was responsible for investigating was 
quite limited: Down syndrome, Turner syndrome, Klinefelter syndrome, Wolf-Hirschhorn 
syndrome, cri du chat syndrome, 5p trisomy, 13 q monosomy, 18p-syndrome, 18q-syndrome, 
and 21 partial monosomy. 54  
In Canada, cytogenetics facilities began as relatively small affairs in the 1960s operating 
in what we have described as the “protective niches” of university-hospital settings which 
provided the resources necessary to nurture what, from the perspective of the institutions housing 
them, was promising clinical research. But, that being said, it becomes increasingly easy to lose 
sight of the individuals working in these facilities after 1970 when the roles of cytogenetics staff 
members became routinely defined and new job categorisations appear in the division of labour 
of the university-hospital settings employing them. The article shows that a push towards ideal-
typical standards of practice and recognition of expertise occurred with the development of a 
mutual awareness among Canadian practitioners of counselling and laboratory services as they 
became increasingly aware that they were involved in a common enterprise.  The emergence of 
closely defined obdurate structures and standards of practice subsequently appeared with the 
establishment of a self-regulating body of de facto specialists: the Canadian College of Medical 
Geneticists (CCMG). Specialty formation was subsequently formally achieved with recognition 
by the Royal College of Physicians and Surgeons of Canada for medical genetics as a new free-
standing medical specialty. At the same time, it is significant that while the occupational role of 
MD-geneticists evolved in relation to the counselling of patients, the role of PhD-geneticists 
became more limited in perspective. PhD-geneticists would become part of a class of technical 
experts functioning only in consultation with the MD-genetics and MSc trained genetic 
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counsellors. While they continued to administer and manage testing facilities, they would cease 
to be directly involved in the counselling of patients.   
By comparison with our account of cytogenetics in Canada, there is a markedly 
pronounced emphasis on the role of the clinical researcher in our account of Mexican 
cytogenetics. Mexico has been remarkably prolific in the development of new knowledge and 
techniques at both the national and international levels. 
It is important to note that prenatal diagnosis and the services of general genetics are 
accessible in most Mexican states – but not all. 55 By the early 1990s, there were one hundred 
and thirty-one specialists certified by the Mexican Board of Human Genetics of which ninety-
seven were registered physicians. At the same time, most of the specialists (ninety-eight) were 
concentrated in the four largest Mexican cities: Mexico City, Guadalajara, Monterrey, and 
Toluca. Further to this, prenatal diagnosis and genetic counselling was available only in one of 
the public hospitals (Mexico City) and a few private hospitals. The main reason for the 
restrictions in access has been the illegality of abortion in most of the Mexican states.  
As in our Canadian account, we began our account of Mexico by focusing on pioneering 
efforts. The focus is here on developments at the National Autonomous University of Mexico 
(UNAM) and the Instituto Mexicano del Seguro Social (IMSS). Salvador Armendares brought 
cytogenetics to these institutions after studies at the British Medical Research Council in Oxford, 
England in the mid-1960s. He was also involved is enmeshing Mexico, along with Argentina, 
Chile, Colombia, and Panama, in the World Health Organization sponsored “International 
Project on Congenital Malformations.” At the same time, it is clear from our account that the 
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same conceptual and technological innovations that impelled the structural development of 
institution-based interests in Canada attracted the interests of governmental bodies and policy 
makers both inside and outside of Mexico. We make mention of, for instance, the establishment 
in the mid-1960s of the Scientific Research Department at the IMSS, funded by a million-dollar 
donation from the (U.S.) Ford Foundation. This coincided with an increased emphasis at the 
UGH on clinical research directly pertaining to general genetics and preventive medicine as well 
as investigation of the structural anomalies of chromosomes linked with malnutrition. 
All in all, it is the involvement of Canadian and Mexican cytogeneticists in the formation 
of national and international circuits of practices and collaborative research that suggest 
promising directions for future historical investigation. We have only begun to touch on how 
Canada and Mexico have been indirectly involved with one another in the growth and 
development of cytogenetics through early exchanges of cytogenetic knowledge, techniques, and 
people.  In addition to the early relationships in Britain and France, Canadian and Mexican 
cytogeneticists have been part of a wider, entangled history involving cytogeneticists from a 
multitude of countries including (and not limited to) Sweden, Italy, Germany, Israel, the United 
States, Paraguay, Argentina, Brazil, Chile, Uruguay, Colombia, Ecuador, Peru, Costa Rica, and 
Japan. What Jürgen Kocka describes as “processes of mutual influencing, in reciprocal or 
asymmetric perceptions, in entangled processes of constituting one another” need further 
exploration if we are to more fully understand the inexorable push to become part of a larger 
movement to develop cytogenetics as a specialised field of laboratory medicine.  56 This, we 
submit, has involved individuals and localities whose interactions deserve to be recognised and 
studied in more than just one journal article.   
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